[1]
Akhtar, M. et al. 2022. Development of Potent SARS-CoV 3CL Protease Inhibitors: In silico Analogues Designing of Darunavir, Molecular Modelling and Molecular Dynamic Simulation. Asian Journal of Chemistry. 34, 9 (Aug. 2022), 2343–2350. DOI:https://doi.org/10.14233/ajchem.2022.23858.